Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Closed-loop tES-non-invasive Stimulation (CLIBM)

15. August 2026 aktualisiert von: Marcus Kaiser, University of Nottingham

Closed-loop Non-invasive Stimulation for Improving Brain and Mental Health in Healthy Individuals

The goal of this study is to establish if non-invasive closed-loop neuromodulation is an effective approach to enhance cognitive function in healthy 18-40 years old volunteers. The main questions it aims to answer are:

  • Can closed-loop stimulation increase stimulation effectiveness?
  • Can closed-loop focused ultrasound specifically engage with excitatory or inhibitory neural populations in the target structure as measured through MRS?
  • Can observed stimulation outcomes for FUS be predicted through connectome analysis and computational models of indirect changes?

Researchers will compare different closed-loop options to their open-loop counterpart to see if closed-loop approaches can increase efficacy and reduce the variability of the stimulation compared to open-loop approaches.

Participants will:

  • Answer some questionnaires at the start of the study and after each intervention session.
  • Undertake a MRI scanning session.
  • Undertake one open-loop FUS session.
  • Undertake one tES session.
  • Undertake one closed-loop FUS sessions involving tES and FUS, followed by a MRI scanning
  • Undertake one sham FUS session
  • Attend one visit in person to assess eligibility through questionnaires and one cognitive task

Studienübersicht

Detaillierte Beschreibung

Closed-loop approaches may offer greater efficacy and lower variability across individuals compared to current open-loop stimulation approaches, yet they remain a relatively new approach, with no studies evaluating closed-loop transcranial low-intensity focused ultrasound stimulation (FUS) yet.

For this reason, we will collect and evaluate cognitive, biological and metabolic data from healthy participants, before and after closed-loop and open-loop stimulation interventions. This will allow us to compare our proposed closed-loop stimulation approach to stablished non-invasive techniques and to investigate the underlying mechanisms through which FUS can alter brain activity.

For this study, participants will attend multiple visits. To assess eligibility, participants will attend one initial session in-person before the start of the study.

Following safety guidelines, each participant will receive a maximum of two 1-hour MRI scanning sessions in a single week.

This study will be separated into two blocks of stimulation sessions: one block for tACS-FUS, and another block for TI-FUS. Participants will be randomly allocated to receive one of the blocks.

Before the during recruitment, participants will be asked to complete online some baseline questionnaires such as the O-Life inventory, BECK, MAIA, or STAI. Furthermore, full eligibility will be assessed in person.

At the first appointment, participants will have a brain scan at Sir Peter Mansfield Imaging Centre or Queen's Medical Centre, Nottingham, UK. This will help us to apply the brain stimulation to the right part of the participant's brain, as well as obtain baseline functional, metabolic and structural information.

Participants will be randomly allocated to either receive open-loop FUS (FUS with Sham tES), closed-loop FUS (dual FUS-tES), tES with Sham FUS, or double sham FUS-tES, in the second appointment and the other interventions in the subsequent visits for their assigned block. During all stimulation sessions, we will use an AntNeuro neuronavigation system to guide the location of the transducer.

During either of the stimulation visits, participants will have physiological (EEG) and cognitive markers recorded. Some emotional assessments (i.e., through a short STAI) will be performed before and after stimulation. EEG recordings will be conducted before, during and after stimulation on the same day. Rest-state EEG will be recorded pre-stimulation before the start of the cognitive tasks, and post-stimulation after the end of the cognitive tasks.

The participant will then undergo one cognitive assessment, which will consists on a visual working memory task (delayed-spatial-estimation-task). The task involves visual stimuli, with responses recorded via keyboard. The task is designed to take approximately 5-15 minutes to complete on pre and post-stimulation. The duration of the task during stimulation will be adapted to the duration of the stimulation. Following this, participants will receive the allocated intervention.

Participants will have the same physiological and cognitive assessments recorded during the stimulation and after the stimulation has been completed. For the closed-loop stimulation, participants will also undergo an MRI scanning after the stimulation.

The first visit, consisting of brain scan, will be separated by at least 24 hours from the second visit. Subsequent visits will be separated by at least one week from each other.

During each consecutive appointment, participants will be asked about any changes to their eligibility and continued consent.

Studientyp

Interventionell

Einschreibung (Geschätzt)

30

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study
  • Aged between 18 and 40
  • Good general health
  • Not consume alcohol 48 hours prior study visit
  • Not currently taking any medications (except contraceptive pills) or if on long-term medication for a non-neurological/non-psychiatric condition (r.g. inhalers) to be considered otherwise healthy and stable with no symptoms
  • Be right handedness

Exclusion Criteria:

  • Inability to complete MRI/FUS/TMS/tES safety questionnaire and / or informed consent process.
  • Current or previous diagnosis of a neurological, neurosurgical, psychiatric disorders.
  • Other significant medical condition (specific details to be reviewed by the CI prior to inclusion).
  • Currently pregnant, breast feeding, or on planned pregnancy.
  • Medication intake (such as beta-blocker, glucocorticoids, anti-depressants, anti-inflammatory drugs in the last 7d).
  • Medication intake (such as antidepressants, antipsychotics, anti-epileptics, beta blockers, glucocorticoids, anti-inflammatories, benzodiazepines, hypnotics, sedating antihistamines or any illicit substances in the past seven days).
  • Significant use of medication or recreational drugs that affect the nervous system.
  • Excessive consumption of alcohol.
  • Known allergy to any required consumables (such as aquasonic gel).
  • History of anaphylaxis to any substance
  • Have tightly coiled, curly or voluminous texture hair type (e.g., hair type 3, 4, or afro hair).
  • Having skin disease or sensitive skin on or close to the head.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Grundlegende Wissenschaft
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Open-loop transcranial low-intensity FUS
Transcranial low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system
Low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system
Andere Namen:
  • TUS
  • LIFU
  • tFUS
We obtain baseline functional, metabolic and structural information through MRI and MRS scanning
Andere Namen:
  • MRT
Experimental: Closed-loop transcranial low-intensity FUS
Closed-loop Transcranial Electrical Stimulation by means of tACS or TI delivered through a Digitimer DS5 for brain entrainment phase-locked on peak or trough to transcranial low intensity FUS delivered to dACC through the NeuroFUS PRO system
Low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system
Andere Namen:
  • TUS
  • LIFU
  • tFUS
We obtain baseline functional, metabolic and structural information through MRI and MRS scanning
Andere Namen:
  • MRT
Transcranial electrical stimulation (by means of transcranial alternating current stimulation (tACS) or non-invasive temporal interference (TI) electrical stimulation) using the DS5 isolated bipolar constant current stimulator together connected to a wave generator and with two electrodes for tACS (TI implementation will be carried out with two DS5 systems, separate wave generators and four electrodes).
Andere Namen:
  • tES
Aktiver Komparator: tES alone
tACS or TI delivered through a Digitimer DS5 for brain entrainment phase-locked on peak or trough
We obtain baseline functional, metabolic and structural information through MRI and MRS scanning
Andere Namen:
  • MRT
Transcranial electrical stimulation (by means of transcranial alternating current stimulation (tACS) or non-invasive temporal interference (TI) electrical stimulation) using the DS5 isolated bipolar constant current stimulator together connected to a wave generator and with two electrodes for tACS (TI implementation will be carried out with two DS5 systems, separate wave generators and four electrodes).
Andere Namen:
  • tES
Aktiver Komparator: Sham FUS
FUS delivered to ventricles or FUS and tACS located on head, one of them on or off depending on sham, or active.
Low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system
Andere Namen:
  • TUS
  • LIFU
  • tFUS
We obtain baseline functional, metabolic and structural information through MRI and MRS scanning
Andere Namen:
  • MRT

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Change from Baseline in EEG Power in Alpha Band (8-12Hz)
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in EEG Power in Theta Band (4-7Hz)
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in EEG Power in Beta Band (13-30Hz)
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in EEG Power in Gamma Band (31-45Hz)
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Changes from Baseline in EEG-derived spectral power
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Changes from Baseline in Functional connectivity (e.g., through changes in Phase-locked value (PLV))
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Average Reaction time (ms) measured from the Visual Working memory task
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Average Overall accuracy (%) measured from Visual Working Memory task
Zeitfenster: Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in Target-Region metabolite Concentration measured via Magnetic Resonance Spectroscopy (MRS)
Zeitfenster: Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Changes from Baseline in Functional Connectivity calculated from functional Magnetic Resonance Imaging (fMRI)
Zeitfenster: Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Changes from Baseline on Structural connectivity metrics derived from multi-shell diffusion MRI (dMRI) tractography
Zeitfenster: Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Baseline (Day 1) to immediately after closed-loop post-stimulation intervention

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Structured questionnaire assessing adverse effects of the intervention
Zeitfenster: Immediately after stimulation, 24 hours after stimulation and 1 week after stimulation
Immediately after stimulation, 24 hours after stimulation and 1 week after stimulation

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Marcus Kaiser, PhD, University of Nottingham

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. September 2026

Primärer Abschluss (Geschätzt)

1. August 2027

Studienabschluss (Geschätzt)

1. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

22. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

22. Juni 2026

Zuerst gepostet (Tatsächlich)

26. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

19. August 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

15. August 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren